Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study

Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis

(2020) L. Barss et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment

(2020) Leila Barss et al.   BMC INFECTIOUS DISEASES

Cost of delivering 12-dose isoniazid and rifapentine versus 6 months of isoniazid for tuberculosis infection in a high-burden setting

(2020) Courtney M Yuen et al.   CLINICAL INFECTIOUS DISEASES

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

(2019) Susan Swindells et al.   NEW ENGLAND JOURNAL OF MEDICINE

TB Preventive Therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen

(2019) Amyn A Malik et al.   CLINICAL INFECTIOUS DISEASES

Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis

(2018) Gibril J. Njie et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection

(2018) Christopher Pease et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Preventive therapy for latent tuberculosis infection—the promise and the challenges

(2017) G.J. Fox et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Screening contacts of patients with extrapulmonary TB for latent TB infection

(2017) Anna Humphreys et al.   THORAX

High prevalence of TB disease in contacts of adults with extrapulmonary TB

(2017) Tom Wingfield et al.   THORAX

Child contact management in high tuberculosis burden countries: A mixed-methods systematic review

(2017) Daria Szkwarko et al.   PLoS One

Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons

(2016) Timothy R. Sterling et al.   AIDS

Initiation and completion rates for latent tuberculosis infection treatment: a systematic review

(2016) Andreas Sandgren et al.   BMC INFECTIOUS DISEASES

The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis

(2016) Hannah Alsdurf et al.   LANCET INFECTIOUS DISEASES

Latent tuberculous infection in the United States and Canada: who completes treatment and why?

(2015) Y. Hirsch-Moverman et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection

(2015) Molebogeng X Rangaka et al.   LANCET

Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste

(2015) Charlotte Hall et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Treatment for Preventing Tuberculosis in Children and Adolescents

(2015) M. Elsa Villarino et al.   JAMA Pediatrics

Prospects for Tuberculosis Elimination

(2012) Christopher Dye et al.   Annual Review of Public Health

Contact investigation for tuberculosis: a systematic review and meta-analysis

(2012) G. J. Fox et al.   EUROPEAN RESPIRATORY JOURNAL

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

(2011) Timothy R. Sterling et al.   NEW ENGLAND JOURNAL OF MEDICINE